Teleflex Incorporated (NYSE:TFX) Receives Average Recommendation of “Hold” from Analysts

by · The Cerbat Gem

Shares of Teleflex Incorporated (NYSE:TFX – Get Free Report) have received an average rating of “Hold” from the eleven brokerages that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating on the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $164.63.

Several brokerages have commented on TFX. Wells Fargo & Company dropped their price target on Teleflex from $146.00 to $137.00 and set an “equal weight” rating on the stock in a research report on Friday, May 2nd. Bank of America cut shares of Teleflex from a “neutral” rating to an “underperform” rating and cut their target price for the company from $235.00 to $140.00 in a research note on Tuesday, March 4th. Truist Financial decreased their price target on shares of Teleflex from $140.00 to $137.00 and set a “hold” rating on the stock in a research report on Monday, May 5th. Piper Sandler reaffirmed a “neutral” rating and set a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Finally, Mizuho set a $155.00 target price on Teleflex in a research report on Wednesday, April 16th.

Get Our Latest Research Report on Teleflex

Hedge Funds Weigh In On Teleflex

A number of hedge funds have recently modified their holdings of TFX. T. Rowe Price Investment Management Inc. boosted its stake in Teleflex by 0.7% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 6,216,763 shares of the medical technology company’s stock valued at $859,095,000 after buying an additional 43,642 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Teleflex by 0.7% in the 4th quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company’s stock valued at $202,161,000 after purchasing an additional 8,307 shares in the last quarter. Cooke & Bieler LP grew its holdings in shares of Teleflex by 22.1% in the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company’s stock worth $191,962,000 after purchasing an additional 195,150 shares during the last quarter. Invesco Ltd. increased its position in shares of Teleflex by 48.1% during the 4th quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company’s stock worth $190,188,000 after purchasing an additional 347,003 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in Teleflex by 69.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company’s stock valued at $119,927,000 after purchasing an additional 355,720 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Price Performance

Shares of Teleflex stock opened at $118.03 on Wednesday. The company has a current ratio of 2.28, a quick ratio of 1.32 and a debt-to-equity ratio of 0.44. The firm has a fifty day simple moving average of $125.44 and a 200-day simple moving average of $149.63. The stock has a market capitalization of $5.22 billion, a price-to-earnings ratio of 37.23, a PEG ratio of 1.85 and a beta of 1.10. Teleflex has a 1-year low of $116.60 and a 1-year high of $249.91.

Teleflex (NYSE:TFX – Get Free Report) last released its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.88 by $0.03. The firm had revenue of $700.67 million during the quarter, compared to analyst estimates of $699.37 million. Teleflex had a net margin of 4.96% and a return on equity of 14.73%. The business’s revenue was down 5.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.21 EPS. On average, sell-side analysts expect that Teleflex will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th were paid a $0.34 dividend. The ex-dividend date was Tuesday, May 20th. This represents a $1.36 annualized dividend and a dividend yield of 1.15%. Teleflex’s dividend payout ratio is currently 42.90%.

Teleflex Company Profile

(Get Free Report

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Articles